

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.11984854 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.11984854 |
| 3 | angiotensin maturation (GO:0002003) | 7.09415617 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.66515771 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.66515771 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.34781928 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.03710533 |
| 8 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.54144483 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.36159855 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.05301373 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.05301373 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.05301373 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.03691609 |
| 14 | lipoprotein transport (GO:0042953) | 4.98640561 |
| 15 | cysteine metabolic process (GO:0006534) | 4.87454223 |
| 16 | intestinal absorption (GO:0050892) | 4.85464481 |
| 17 | tryptophan metabolic process (GO:0006568) | 4.82855698 |
| 18 | hormone catabolic process (GO:0042447) | 4.81836516 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 4.80144847 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.72849151 |
| 21 | plasma lipoprotein particle assembly (GO:0034377) | 4.61862496 |
| 22 | kynurenine metabolic process (GO:0070189) | 4.60201156 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 4.58240856 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.46574436 |
| 25 | aromatic amino acid family metabolic process (GO:0009072) | 4.37888025 |
| 26 | tyrosine metabolic process (GO:0006570) | 4.35461333 |
| 27 | lysine catabolic process (GO:0006554) | 4.35117650 |
| 28 | lysine metabolic process (GO:0006553) | 4.35117650 |
| 29 | sulfate transmembrane transport (GO:1902358) | 4.35012684 |
| 30 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.31956965 |
| 31 | short-chain fatty acid metabolic process (GO:0046459) | 4.30598379 |
| 32 | drug transmembrane transport (GO:0006855) | 4.30479971 |
| 33 | drug catabolic process (GO:0042737) | 4.26417428 |
| 34 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.26301601 |
| 35 | bile acid metabolic process (GO:0008206) | 4.23379094 |
| 36 | ethanol oxidation (GO:0006069) | 4.23135557 |
| 37 | regulation of guanylate cyclase activity (GO:0031282) | 4.21718509 |
| 38 | high-density lipoprotein particle remodeling (GO:0034375) | 4.21117432 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 4.16017018 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.13505360 |
| 41 | alpha-amino acid catabolic process (GO:1901606) | 4.10511841 |
| 42 | cellular ketone body metabolic process (GO:0046950) | 4.06693676 |
| 43 | negative regulation of fibrinolysis (GO:0051918) | 4.06347531 |
| 44 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.06207721 |
| 45 | protein carboxylation (GO:0018214) | 4.06207721 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.03948821 |
| 47 | sphingoid metabolic process (GO:0046519) | 4.02976428 |
| 48 | complement activation, alternative pathway (GO:0006957) | 4.01799781 |
| 49 | regulation of fibrinolysis (GO:0051917) | 4.01532508 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 3.99151754 |
| 51 | protein-lipid complex assembly (GO:0065005) | 3.98391075 |
| 52 | regulation of protein glycosylation (GO:0060049) | 3.96595728 |
| 53 | urea metabolic process (GO:0019627) | 3.96349404 |
| 54 | urea cycle (GO:0000050) | 3.96349404 |
| 55 | urate metabolic process (GO:0046415) | 3.95626712 |
| 56 | regulation of protein activation cascade (GO:2000257) | 3.89832257 |
| 57 | vitamin transmembrane transport (GO:0035461) | 3.89198840 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 3.87427362 |
| 59 | sphingosine metabolic process (GO:0006670) | 3.87273296 |
| 60 | acetyl-CoA metabolic process (GO:0006084) | 3.83479814 |
| 61 | regulation of cholesterol esterification (GO:0010872) | 3.82965100 |
| 62 | fatty acid elongation (GO:0030497) | 3.82367953 |
| 63 | diol metabolic process (GO:0034311) | 3.78302053 |
| 64 | nitrogen cycle metabolic process (GO:0071941) | 3.76445640 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 3.76395749 |
| 66 | triglyceride homeostasis (GO:0070328) | 3.76226768 |
| 67 | acylglycerol homeostasis (GO:0055090) | 3.76226768 |
| 68 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.74953205 |
| 69 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.74953205 |
| 70 | NADH metabolic process (GO:0006734) | 3.74631812 |
| 71 | very long-chain fatty acid metabolic process (GO:0000038) | 3.74603803 |
| 72 | coenzyme catabolic process (GO:0009109) | 3.74482385 |
| 73 | cellular glucuronidation (GO:0052695) | 3.74201749 |
| 74 | diacylglycerol metabolic process (GO:0046339) | 3.72919888 |
| 75 | fatty acid beta-oxidation (GO:0006635) | 3.72072517 |
| 76 | amine catabolic process (GO:0009310) | 3.71873019 |
| 77 | cellular biogenic amine catabolic process (GO:0042402) | 3.71873019 |
| 78 | positive regulation of lipid catabolic process (GO:0050996) | 3.71283938 |
| 79 | fatty acid oxidation (GO:0019395) | 3.70704497 |
| 80 | reverse cholesterol transport (GO:0043691) | 3.70627942 |
| 81 | exogenous drug catabolic process (GO:0042738) | 3.68845934 |
| 82 | indolalkylamine metabolic process (GO:0006586) | 3.68813035 |
| 83 | endocrine process (GO:0050886) | 3.67129316 |
| 84 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.67129316 |
| 85 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.67129316 |
| 86 | aldehyde catabolic process (GO:0046185) | 3.66224058 |
| 87 | regulation of complement activation (GO:0030449) | 3.65985908 |
| 88 | glutamate metabolic process (GO:0006536) | 3.65984074 |
| 89 | protein-lipid complex remodeling (GO:0034368) | 3.64925546 |
| 90 | macromolecular complex remodeling (GO:0034367) | 3.64925546 |
| 91 | plasma lipoprotein particle remodeling (GO:0034369) | 3.64925546 |
| 92 | L-ascorbic acid metabolic process (GO:0019852) | 3.64848987 |
| 93 | lipid oxidation (GO:0034440) | 3.64833835 |
| 94 | aspartate family amino acid catabolic process (GO:0009068) | 3.62802479 |
| 95 | sterol homeostasis (GO:0055092) | 3.61253234 |
| 96 | uronic acid metabolic process (GO:0006063) | 3.59172110 |
| 97 | glucuronate metabolic process (GO:0019585) | 3.59172110 |
| 98 | carboxylic acid catabolic process (GO:0046395) | 3.59052004 |
| 99 | organic acid catabolic process (GO:0016054) | 3.59052004 |
| 100 | benzene-containing compound metabolic process (GO:0042537) | 3.56527507 |
| 101 | ketone body metabolic process (GO:1902224) | 3.55116892 |
| 102 | monocarboxylic acid catabolic process (GO:0072329) | 3.54315791 |
| 103 | serine family amino acid metabolic process (GO:0009069) | 3.52689360 |
| 104 | cellular modified amino acid catabolic process (GO:0042219) | 3.52325204 |
| 105 | protein-chromophore linkage (GO:0018298) | 3.52143095 |
| 106 | fatty acid catabolic process (GO:0009062) | 3.51505152 |
| 107 | fructose metabolic process (GO:0006000) | 3.51207162 |
| 108 | trivalent inorganic anion homeostasis (GO:0072506) | 3.49777751 |
| 109 | phosphate ion homeostasis (GO:0055062) | 3.49777751 |
| 110 | lipoprotein metabolic process (GO:0042157) | 3.46859680 |
| 111 | sulfate transport (GO:0008272) | 3.46841498 |
| 112 | iron coordination entity transport (GO:1901678) | 3.46736694 |
| 113 | branched-chain amino acid catabolic process (GO:0009083) | 3.46552938 |
| 114 | omega-hydroxylase P450 pathway (GO:0097267) | 3.45848644 |
| 115 | regulation of systemic arterial blood pressure (GO:0003073) | 3.45667237 |
| 116 | valine metabolic process (GO:0006573) | 3.44972078 |
| 117 | * drug metabolic process (GO:0017144) | 3.44766183 |
| 118 | regulation of bile acid biosynthetic process (GO:0070857) | 3.43823982 |
| 119 | drug transport (GO:0015893) | 3.42532228 |
| 120 | excretion (GO:0007588) | 3.41868916 |
| 121 | transepithelial transport (GO:0070633) | 3.40235175 |
| 122 | phospholipid efflux (GO:0033700) | 3.39473612 |
| 123 | regulation of lipoprotein metabolic process (GO:0050746) | 3.39278091 |
| 124 | heme transport (GO:0015886) | 3.38050474 |
| 125 | vitamin transport (GO:0051180) | 3.36591542 |
| 126 | glycerol metabolic process (GO:0006071) | 3.35767622 |
| 127 | cholesterol efflux (GO:0033344) | 3.35371253 |
| 128 | negative regulation of cholesterol transport (GO:0032375) | 3.34298185 |
| 129 | negative regulation of sterol transport (GO:0032372) | 3.34298185 |
| 130 | branched-chain amino acid metabolic process (GO:0009081) | 3.32463199 |
| 131 | flavonoid metabolic process (GO:0009812) | 3.31908965 |
| 132 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.31414237 |
| 133 | serine family amino acid biosynthetic process (GO:0009070) | 3.30075523 |
| 134 | regulation of cholesterol metabolic process (GO:0090181) | 3.29304632 |
| 135 | ethanol metabolic process (GO:0006067) | 3.28452300 |
| 136 | bile acid and bile salt transport (GO:0015721) | 3.28378553 |
| 137 | response to mercury ion (GO:0046689) | 3.26791254 |
| 138 | adhesion of symbiont to host cell (GO:0044650) | 3.24723517 |
| 139 | virion attachment to host cell (GO:0019062) | 3.24723517 |
| 140 | negative regulation of lipase activity (GO:0060192) | 3.24546390 |
| 141 | alkaloid metabolic process (GO:0009820) | 3.22732820 |
| 142 | plasma lipoprotein particle organization (GO:0071827) | 3.22417583 |
| 143 | arginine metabolic process (GO:0006525) | 3.20760587 |
| 144 | cholesterol homeostasis (GO:0042632) | 3.20668265 |
| 145 | cofactor catabolic process (GO:0051187) | 3.20446742 |
| 146 | acyl-CoA metabolic process (GO:0006637) | 3.20430839 |
| 147 | drinking behavior (GO:0042756) | 3.13656822 |
| 148 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.13270460 |
| 149 | digestion (GO:0007586) | 3.12470784 |
| 150 | vitamin biosynthetic process (GO:0009110) | 3.12392408 |
| 151 | cellular response to nitric oxide (GO:0071732) | 3.10500070 |
| 152 | alditol metabolic process (GO:0019400) | 3.06752178 |
| 153 | vitamin D metabolic process (GO:0042359) | 3.06535777 |
| 154 | regulation of digestive system process (GO:0044058) | 3.05759353 |
| 155 | sulfur compound transport (GO:0072348) | 3.01629737 |
| 156 | fat-soluble vitamin metabolic process (GO:0006775) | 3.01153739 |
| 157 | sulfation (GO:0051923) | 2.99058269 |
| 158 | protein-lipid complex subunit organization (GO:0071825) | 2.96248014 |
| 159 | phospholipid homeostasis (GO:0055091) | 2.95031875 |
| 160 | adhesion of symbiont to host (GO:0044406) | 2.84009538 |
| 161 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.79525005 |
| 162 | regulation of cGMP biosynthetic process (GO:0030826) | 2.78221956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.58279857 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.18901925 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.17790852 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.08426744 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.05243199 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.40439217 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.00202729 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.51302290 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.04130202 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.80282266 |
| 11 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.83935542 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.79170015 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.73757187 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.73637195 |
| 15 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.67428870 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64981136 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.63947275 |
| 18 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.59024374 |
| 19 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.58543375 |
| 20 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.57284930 |
| 21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.57080624 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.54572313 |
| 23 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.49547671 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.49017103 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46107670 |
| 26 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.45642801 |
| 27 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.42588312 |
| 28 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.42588312 |
| 29 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.42414880 |
| 30 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.41686952 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38661888 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.38423574 |
| 33 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.36682456 |
| 34 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.36489442 |
| 35 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.34863273 |
| 36 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29644886 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.28582335 |
| 38 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27431061 |
| 39 | RXR_22108803_ChIP-Seq_LS180_Human | 1.27196379 |
| 40 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25856877 |
| 41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25856877 |
| 42 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.24497125 |
| 43 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.24191587 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23877303 |
| 45 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22141301 |
| 46 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.21742245 |
| 47 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.21305013 |
| 48 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20611669 |
| 49 | NCOR_22424771_ChIP-Seq_293T_Human | 1.18804201 |
| 50 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.18152368 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17187657 |
| 52 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.16459879 |
| 53 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15716111 |
| 54 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15584623 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14142553 |
| 56 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.14128970 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13865838 |
| 58 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.13430668 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13149164 |
| 60 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12619697 |
| 61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10490436 |
| 62 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.10391190 |
| 63 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.10391190 |
| 64 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10295641 |
| 65 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.08012768 |
| 66 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.08012768 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07867427 |
| 68 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07119476 |
| 69 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05311040 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04653180 |
| 71 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.04502587 |
| 72 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04448869 |
| 73 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04377342 |
| 74 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.03815961 |
| 75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03461691 |
| 76 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.03283374 |
| 77 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.02977091 |
| 78 | AR_20517297_ChIP-Seq_VCAP_Human | 1.02965431 |
| 79 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02648377 |
| 80 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02567265 |
| 81 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02033490 |
| 82 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.01150326 |
| 83 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.01150030 |
| 84 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01097637 |
| 85 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00242720 |
| 86 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.99065156 |
| 87 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.98225374 |
| 88 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.97508912 |
| 89 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.96539432 |
| 90 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92195711 |
| 91 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89709128 |
| 92 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89679581 |
| 93 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88158355 |
| 94 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87364962 |
| 95 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86872677 |
| 96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86827449 |
| 97 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85315907 |
| 98 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.82654359 |
| 99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82068632 |
| 100 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81202012 |
| 101 | VDR_22108803_ChIP-Seq_LS180_Human | 0.80611343 |
| 102 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.79864339 |
| 103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.79653658 |
| 104 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.79592149 |
| 105 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79319932 |
| 106 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.79305080 |
| 107 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78322257 |
| 108 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77815369 |
| 109 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.77139047 |
| 110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.76862373 |
| 111 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.75680260 |
| 112 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.74853018 |
| 113 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.74677797 |
| 114 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.74156314 |
| 115 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.73258947 |
| 116 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.73238428 |
| 117 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.72593324 |
| 118 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.72269086 |
| 119 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.72259748 |
| 120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71224813 |
| 121 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.70896536 |
| 122 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.70705269 |
| 123 | CBP_21632823_ChIP-Seq_H3396_Human | 0.69866802 |
| 124 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.67634659 |
| 125 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.67633133 |
| 126 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.67525412 |
| 127 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.67018271 |
| 128 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.66994004 |
| 129 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.65277205 |
| 130 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.64948913 |
| 131 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.64727283 |
| 132 | P300_19829295_ChIP-Seq_ESCs_Human | 0.64482453 |
| 133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64432773 |
| 134 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.64397580 |
| 135 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.63965679 |
| 136 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.63779892 |
| 137 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.62823766 |
| 138 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.62030490 |
| 139 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.61992420 |
| 140 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.61846326 |
| 141 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.61753692 |
| 142 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.60950663 |
| 143 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.60812414 |
| 144 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.60720953 |
| 145 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60688477 |
| 146 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.60323154 |
| 147 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60024653 |
| 148 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.59283656 |
| 149 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.59230782 |
| 150 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.59198743 |
| 151 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.59030424 |
| 152 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.58898997 |
| 153 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.58846538 |
| 154 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.58625781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.26825330 |
| 2 | MP0005360_urolithiasis | 7.04843108 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.20536232 |
| 4 | MP0005365_abnormal_bile_salt | 5.09763001 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.06528297 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.62104660 |
| 7 | MP0003252_abnormal_bile_duct | 3.24181027 |
| 8 | MP0005332_abnormal_amino_acid | 3.19707791 |
| 9 | MP0003195_calcinosis | 3.12746173 |
| 10 | MP0003136_yellow_coat_color | 3.05816606 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.98844474 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.74096682 |
| 13 | MP0005083_abnormal_biliary_tract | 2.53168035 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.51843479 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.42252503 |
| 16 | MP0004264_abnormal_extraembryonic_tissu | 2.38897991 |
| 17 | MP0009840_abnormal_foam_cell | 2.34862077 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.09232301 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.04763154 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.02619719 |
| 21 | MP0004043_abnormal_pH_regulation | 1.96266435 |
| 22 | MP0003890_abnormal_embryonic-extraembry | 1.95062364 |
| 23 | MP0003879_abnormal_hair_cell | 1.83377043 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.80824839 |
| 25 | MP0002653_abnormal_ependyma_morphology | 1.79172035 |
| 26 | MP0003045_fibrosis | 1.77371944 |
| 27 | MP0000609_abnormal_liver_physiology | 1.74850584 |
| 28 | MP0005171_absent_coat_pigmentation | 1.66609966 |
| 29 | MP0005451_abnormal_body_composition | 1.66251414 |
| 30 | MP0003690_abnormal_glial_cell | 1.65546794 |
| 31 | MP0009379_abnormal_foot_pigmentation | 1.64093459 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63570188 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.54406240 |
| 34 | MP0003186_abnormal_redox_activity | 1.52609903 |
| 35 | MP0010368_abnormal_lymphatic_system | 1.43749089 |
| 36 | MP0001764_abnormal_homeostasis | 1.42025564 |
| 37 | MP0002938_white_spotting | 1.40646544 |
| 38 | MP0005408_hypopigmentation | 1.36839166 |
| 39 | MP0003868_abnormal_feces_composition | 1.34979304 |
| 40 | MP0005670_abnormal_white_adipose | 1.34974311 |
| 41 | MP0000920_abnormal_myelination | 1.32300370 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 1.32173907 |
| 43 | MP0003724_increased_susceptibility_to | 1.28558401 |
| 44 | MP0005503_abnormal_tendon_morphology | 1.28033646 |
| 45 | MP0008872_abnormal_physiological_respon | 1.26016324 |
| 46 | MP0001661_extended_life_span | 1.24207033 |
| 47 | MP0004147_increased_porphyrin_level | 1.16963073 |
| 48 | MP0001485_abnormal_pinna_reflex | 1.16627767 |
| 49 | MP0009697_abnormal_copulation | 1.15688284 |
| 50 | MP0000604_amyloidosis | 1.12594699 |
| 51 | MP0003329_amyloid_beta_deposits | 1.12182553 |
| 52 | MP0001501_abnormal_sleep_pattern | 1.12180976 |
| 53 | MP0003011_delayed_dark_adaptation | 1.11777999 |
| 54 | MP0003646_muscle_fatigue | 1.11456098 |
| 55 | MP0001664_abnormal_digestion | 1.06141530 |
| 56 | MP0005275_abnormal_skin_tensile | 1.05061689 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.04876418 |
| 58 | MP0001756_abnormal_urination | 1.03771922 |
| 59 | MP0003718_maternal_effect | 1.02723008 |
| 60 | MP0006054_spinal_hemorrhage | 1.02688502 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.00399191 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 0.99888831 |
| 63 | MP0009764_decreased_sensitivity_to | 0.99075548 |
| 64 | MP0002971_abnormal_brown_adipose | 0.94110297 |
| 65 | MP0005535_abnormal_body_temperature | 0.92863768 |
| 66 | MP0005647_abnormal_sex_gland | 0.91497724 |
| 67 | MP0008961_abnormal_basal_metabolism | 0.91266857 |
| 68 | MP0002136_abnormal_kidney_physiology | 0.89509377 |
| 69 | MP0002638_abnormal_pupillary_reflex | 0.88179269 |
| 70 | MP0005666_abnormal_adipose_tissue | 0.88153106 |
| 71 | MP0004130_abnormal_muscle_cell | 0.87272083 |
| 72 | MP0005551_abnormal_eye_electrophysiolog | 0.86974815 |
| 73 | MP0006036_abnormal_mitochondrial_physio | 0.86344897 |
| 74 | MP0001765_abnormal_ion_homeostasis | 0.84589494 |
| 75 | MP0009763_increased_sensitivity_to | 0.83250897 |
| 76 | MP0000598_abnormal_liver_morphology | 0.82104032 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 0.79757960 |
| 78 | MP0009642_abnormal_blood_homeostasis | 0.79494172 |
| 79 | MP0005377_hearing/vestibular/ear_phenot | 0.78283581 |
| 80 | MP0003878_abnormal_ear_physiology | 0.78283581 |
| 81 | MP0005058_abnormal_lysosome_morphology | 0.77804128 |
| 82 | MP0009115_abnormal_fat_cell | 0.77121898 |
| 83 | MP0002254_reproductive_system_inflammat | 0.74295569 |
| 84 | MP0000230_abnormal_systemic_arterial | 0.73624005 |
| 85 | MP0010155_abnormal_intestine_physiology | 0.73321104 |
| 86 | MP0002295_abnormal_pulmonary_circulatio | 0.73042195 |
| 87 | MP0008469_abnormal_protein_level | 0.73013348 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.70368100 |
| 89 | MP0005334_abnormal_fat_pad | 0.70128386 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 0.69938307 |
| 91 | MP0005376_homeostasis/metabolism_phenot | 0.69799080 |
| 92 | MP0003950_abnormal_plasma_membrane | 0.65132965 |
| 93 | MP0001879_abnormal_lymphatic_vessel | 0.63717876 |
| 94 | MP0004885_abnormal_endolymph | 0.63650759 |
| 95 | MP0000566_synostosis | 0.63637263 |
| 96 | MP0004782_abnormal_surfactant_physiolog | 0.61714076 |
| 97 | MP0000427_abnormal_hair_cycle | 0.60500202 |
| 98 | MP0005595_abnormal_vascular_smooth | 0.60248557 |
| 99 | MP0002837_dystrophic_cardiac_calcinosis | 0.59964541 |
| 100 | MP0004381_abnormal_hair_follicle | 0.57279518 |
| 101 | MP0003638_abnormal_response/metabolism_ | 0.56665026 |
| 102 | MP0002277_abnormal_respiratory_mucosa | 0.54216717 |
| 103 | MP0004185_abnormal_adipocyte_glucose | 0.53851036 |
| 104 | MP0002135_abnormal_kidney_morphology | 0.53640549 |
| 105 | MP0000534_abnormal_ureter_morphology | 0.53639064 |
| 106 | MP0010352_gastrointestinal_tract_polyps | 0.53435604 |
| 107 | MP0005174_abnormal_tail_pigmentation | 0.52414828 |
| 108 | MP0002736_abnormal_nociception_after | 0.51981300 |
| 109 | MP0002168_other_aberrant_phenotype | 0.51499077 |
| 110 | MP0005164_abnormal_response_to | 0.51478559 |
| 111 | MP0005220_abnormal_exocrine_pancreas | 0.50983165 |
| 112 | MP0001324_abnormal_eye_pigmentation | 0.50364566 |
| 113 | MP0005395_other_phenotype | 0.49802333 |
| 114 | MP0001958_emphysema | 0.49437845 |
| 115 | MP0002735_abnormal_chemical_nociception | 0.49315385 |
| 116 | MP0000639_abnormal_adrenal_gland | 0.47122396 |
| 117 | MP0004272_abnormal_basement_membrane | 0.47025822 |
| 118 | MP0005409_darkened_coat_color | 0.46683251 |
| 119 | MP0005075_abnormal_melanosome_morpholog | 0.46653477 |
| 120 | MP0003633_abnormal_nervous_system | 0.46534070 |
| 121 | MP0001986_abnormal_taste_sensitivity | 0.46364472 |
| 122 | MP0000249_abnormal_blood_vessel | 0.45215185 |
| 123 | MP0004215_abnormal_myocardial_fiber | 0.44461596 |
| 124 | MP0002928_abnormal_bile_duct | 0.44252065 |
| 125 | MP0005375_adipose_tissue_phenotype | 0.43709726 |
| 126 | MP0003075_altered_response_to | 0.42834186 |
| 127 | MP0005448_abnormal_energy_balance | 0.42773518 |
| 128 | MP0004883_abnormal_blood_vessel | 0.42645982 |
| 129 | MP0008874_decreased_physiological_sensi | 0.41385325 |
| 130 | MP0009384_cardiac_valve_regurgitation | 0.40465805 |
| 131 | MP0003953_abnormal_hormone_level | 0.40454739 |
| 132 | MP0003866_abnormal_defecation | 0.39078908 |
| 133 | MP0005646_abnormal_pituitary_gland | 0.38709281 |
| 134 | MP0005266_abnormal_metabolism | 0.38553508 |
| 135 | MP0006082_CNS_inflammation | 0.38526248 |
| 136 | MP0005165_increased_susceptibility_to | 0.37858022 |
| 137 | MP0003631_nervous_system_phenotype | 0.37454304 |
| 138 | MP0005410_abnormal_fertilization | 0.36491654 |
| 139 | MP0002796_impaired_skin_barrier | 0.35972507 |
| 140 | MP0000026_abnormal_inner_ear | 0.35948341 |
| 141 | MP0000477_abnormal_intestine_morphology | 0.35703856 |
| 142 | MP0003632_abnormal_nervous_system | 0.35678071 |
| 143 | MP0000538_abnormal_urinary_bladder | 0.35492723 |
| 144 | MP0002822_catalepsy | 0.35301080 |
| 145 | MP0005166_decreased_susceptibility_to | 0.35156588 |
| 146 | MP0000516_abnormal_urinary_system | 0.34549215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.50353739 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.85099528 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.63146963 |
| 4 | Xanthomatosis (HP:0000991) | 5.15566433 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 4.88326439 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.81060826 |
| 7 | Acanthocytosis (HP:0001927) | 4.67926949 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.61595613 |
| 9 | Facial shape deformation (HP:0011334) | 4.51401405 |
| 10 | Potter facies (HP:0002009) | 4.51401405 |
| 11 | Hyperglycinuria (HP:0003108) | 4.42756261 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 4.39355098 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.39355098 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 4.34966024 |
| 15 | Ketosis (HP:0001946) | 4.12857383 |
| 16 | Hyperammonemia (HP:0001987) | 4.10830291 |
| 17 | Pigmentary retinal degeneration (HP:0001146) | 4.10509599 |
| 18 | Hyperglycinemia (HP:0002154) | 4.08369517 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.97485432 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.91820308 |
| 21 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.87412418 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.80282695 |
| 23 | Complement deficiency (HP:0004431) | 3.79794999 |
| 24 | Joint hemorrhage (HP:0005261) | 3.72757502 |
| 25 | Abnormality of vitamin B metabolism (HP:0004340) | 3.67505975 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.63608869 |
| 27 | Abnormality of magnesium homeostasis (HP:0004921) | 3.51122539 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.49297128 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.45089163 |
| 30 | Hypolipoproteinemia (HP:0010981) | 3.42196109 |
| 31 | Epidermoid cyst (HP:0200040) | 3.39018033 |
| 32 | Ketoacidosis (HP:0001993) | 3.38602690 |
| 33 | Ileus (HP:0002595) | 3.36696840 |
| 34 | Fat malabsorption (HP:0002630) | 3.36289111 |
| 35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.34724141 |
| 36 | Widely patent fontanelles and sutures (HP:0004492) | 3.31356713 |
| 37 | Nausea (HP:0002018) | 3.25837316 |
| 38 | Chronic diarrhea (HP:0002028) | 3.22495791 |
| 39 | Hypoalphalipoproteinemia (HP:0003233) | 3.15914898 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.15262855 |
| 41 | Abnormality of the common coagulation pathway (HP:0010990) | 3.14357180 |
| 42 | Hypokalemic alkalosis (HP:0001949) | 3.12055727 |
| 43 | Decreased circulating renin level (HP:0003351) | 3.09300183 |
| 44 | Gout (HP:0001997) | 3.07170587 |
| 45 | Hypokalemia (HP:0002900) | 3.06943040 |
| 46 | Alkalosis (HP:0001948) | 3.05947926 |
| 47 | Conjugated hyperbilirubinemia (HP:0002908) | 3.02994348 |
| 48 | Delayed CNS myelination (HP:0002188) | 3.01691821 |
| 49 | Dicarboxylic aciduria (HP:0003215) | 3.00182693 |
| 50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.00182693 |
| 51 | Vascular calcification (HP:0004934) | 2.98572473 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.95883367 |
| 53 | Increased circulating renin level (HP:0000848) | 2.92654000 |
| 54 | Hyperaldosteronism (HP:0000859) | 2.88728975 |
| 55 | Amelogenesis imperfecta (HP:0000705) | 2.88138082 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.87747525 |
| 57 | Metabolic acidosis (HP:0001942) | 2.83845259 |
| 58 | Proximal tubulopathy (HP:0000114) | 2.79333182 |
| 59 | Abnormality of serum amino acid levels (HP:0003112) | 2.77082342 |
| 60 | Lethargy (HP:0001254) | 2.75415892 |
| 61 | Nephrolithiasis (HP:0000787) | 2.74345216 |
| 62 | Abnormality of nucleobase metabolism (HP:0010932) | 2.74242584 |
| 63 | Hypercholesterolemia (HP:0003124) | 2.72509352 |
| 64 | Abnormality of urine glucose concentration (HP:0011016) | 2.68965204 |
| 65 | Glycosuria (HP:0003076) | 2.68965204 |
| 66 | Hyperactive renin-angiotensin system (HP:0000841) | 2.68670376 |
| 67 | Enlarged epiphyses (HP:0010580) | 2.66472867 |
| 68 | Steatorrhea (HP:0002570) | 2.65616643 |
| 69 | Abnormality of the intrinsic pathway (HP:0010989) | 2.63569794 |
| 70 | Tetany (HP:0001281) | 2.61480411 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.61313633 |
| 72 | Congenital sensorineural hearing impairment (HP:0008527) | 2.59549706 |
| 73 | Cerebral edema (HP:0002181) | 2.59495660 |
| 74 | Abnormality of potassium homeostasis (HP:0011042) | 2.57179350 |
| 75 | Hyperbilirubinemia (HP:0002904) | 2.56075573 |
| 76 | Megaloblastic anemia (HP:0001889) | 2.55289057 |
| 77 | Metabolic alkalosis (HP:0200114) | 2.54655747 |
| 78 | Hypophosphatemic rickets (HP:0004912) | 2.53440771 |
| 79 | Abnormality of complement system (HP:0005339) | 2.53403937 |
| 80 | Vomiting (HP:0002013) | 2.46333005 |
| 81 | Enlarged kidneys (HP:0000105) | 2.45425926 |
| 82 | Rickets (HP:0002748) | 2.42408195 |
| 83 | Hepatocellular carcinoma (HP:0001402) | 2.40010085 |
| 84 | Neurofibrillary tangles (HP:0002185) | 2.39515907 |
| 85 | Hypomagnesemia (HP:0002917) | 2.33330321 |
| 86 | Parakeratosis (HP:0001036) | 2.33227411 |
| 87 | Hypoglycemic seizures (HP:0002173) | 2.31746331 |
| 88 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.30961017 |
| 89 | Irritability (HP:0000737) | 2.27676356 |
| 90 | Confusion (HP:0001289) | 2.27170693 |
| 91 | Increased purine levels (HP:0004368) | 2.26027379 |
| 92 | Hyperuricemia (HP:0002149) | 2.26027379 |
| 93 | Amyloidosis (HP:0011034) | 2.25781191 |
| 94 | Poikilocytosis (HP:0004447) | 2.21548301 |
| 95 | Cerebral hemorrhage (HP:0001342) | 2.21113835 |
| 96 | Hyperventilation (HP:0002883) | 2.18653196 |
| 97 | Malnutrition (HP:0004395) | 2.13018293 |
| 98 | Opisthotonus (HP:0002179) | 2.12547543 |
| 99 | Myocardial infarction (HP:0001658) | 2.11691576 |
| 100 | Pancreatitis (HP:0001733) | 2.10503051 |
| 101 | Cerebral palsy (HP:0100021) | 2.09561358 |
| 102 | Hydroxyprolinuria (HP:0003080) | 2.08852084 |
| 103 | Abnormality of proline metabolism (HP:0010907) | 2.08852084 |
| 104 | Hypophosphatemia (HP:0002148) | 2.08706560 |
| 105 | Chorioretinal atrophy (HP:0000533) | 2.08472043 |
| 106 | Polyuria (HP:0000103) | 2.07880270 |
| 107 | Wide cranial sutures (HP:0010537) | 2.01422438 |
| 108 | Abnormal urine output (HP:0012590) | 2.01394155 |
| 109 | Mitral stenosis (HP:0001718) | 2.00896999 |
| 110 | Methylmalonic aciduria (HP:0012120) | 2.00191055 |
| 111 | Long clavicles (HP:0000890) | 1.99926928 |
| 112 | Hyperphosphaturia (HP:0003109) | 1.99367494 |
| 113 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99263009 |
| 114 | Renal cortical cysts (HP:0000803) | 1.97534105 |
| 115 | Systemic lupus erythematosus (HP:0002725) | 1.97145812 |
| 116 | Abnormality of chloride homeostasis (HP:0011422) | 1.96345642 |
| 117 | Dehydration (HP:0001944) | 1.96034561 |
| 118 | Esophageal varix (HP:0002040) | 1.95443329 |
| 119 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.95429166 |
| 120 | Abnormality of vitamin metabolism (HP:0100508) | 1.94189867 |
| 121 | Osteomalacia (HP:0002749) | 1.93935598 |
| 122 | Spontaneous abortion (HP:0005268) | 1.93636272 |
| 123 | Ulnar claw (HP:0001178) | 1.93043522 |
| 124 | Pancreatic cysts (HP:0001737) | 1.92666336 |
| 125 | Abnormality of the renal cortex (HP:0011035) | 1.92351593 |
| 126 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.91871008 |
| 127 | Hypoplasia of the fovea (HP:0007750) | 1.91871008 |
| 128 | Brushfield spots (HP:0001088) | 1.91259977 |
| 129 | Skin nodule (HP:0200036) | 1.90785741 |
| 130 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.89730368 |
| 131 | Hemorrhage of the eye (HP:0011885) | 1.89175467 |
| 132 | Abnormal gallbladder morphology (HP:0012437) | 1.86365604 |
| 133 | Abnormality of renal excretion (HP:0011036) | 1.86238425 |
| 134 | Glomerulonephritis (HP:0000099) | 1.85567639 |
| 135 | Abnormal urine phosphate concentration (HP:0012599) | 1.85318270 |
| 136 | Axonal loss (HP:0003447) | 1.85004054 |
| 137 | Tubular atrophy (HP:0000092) | 1.84373845 |
| 138 | Abnormality of renin-angiotensin system (HP:0000847) | 1.84292059 |
| 139 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83741897 |
| 140 | Hypercalciuria (HP:0002150) | 1.82865870 |
| 141 | Renal salt wasting (HP:0000127) | 1.82718282 |
| 142 | Acute encephalopathy (HP:0006846) | 1.82408480 |
| 143 | Abnormal drinking behavior (HP:0030082) | 1.81665862 |
| 144 | Polydipsia (HP:0001959) | 1.81665862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.34388095 |
| 2 | BCKDK | 4.58348414 |
| 3 | STK39 | 4.57892144 |
| 4 | WNK4 | 3.96621835 |
| 5 | OXSR1 | 3.94948367 |
| 6 | INSRR | 2.91768662 |
| 7 | TIE1 | 2.88502663 |
| 8 | EPHB1 | 2.84616137 |
| 9 | FGFR4 | 2.70042028 |
| 10 | LATS2 | 2.41194740 |
| 11 | SIK1 | 2.41044574 |
| 12 | ZAK | 2.39298383 |
| 13 | FGFR2 | 2.33472136 |
| 14 | ADRBK2 | 2.04392888 |
| 15 | MET | 1.85005591 |
| 16 | MAPK15 | 1.81912327 |
| 17 | SGK494 | 1.68726484 |
| 18 | SGK223 | 1.68726484 |
| 19 | WNK3 | 1.68496864 |
| 20 | EIF2AK3 | 1.64779505 |
| 21 | ERBB4 | 1.64285336 |
| 22 | PKN1 | 1.55590304 |
| 23 | TAOK3 | 1.48174719 |
| 24 | PBK | 1.46840134 |
| 25 | ERN1 | 1.44225687 |
| 26 | MAP3K2 | 1.41750197 |
| 27 | KDR | 1.41454068 |
| 28 | MST1R | 1.40688507 |
| 29 | STK3 | 1.38374400 |
| 30 | PRKG2 | 1.35756734 |
| 31 | BCR | 1.25983661 |
| 32 | MST4 | 1.24075278 |
| 33 | WNK1 | 1.14606253 |
| 34 | MELK | 1.13559210 |
| 35 | PRKAA2 | 1.12578083 |
| 36 | PIK3CG | 1.12027330 |
| 37 | TGFBR1 | 1.11620373 |
| 38 | NUAK1 | 1.06107314 |
| 39 | GRK1 | 1.05273020 |
| 40 | STK38 | 1.04992861 |
| 41 | TGFBR2 | 1.04712493 |
| 42 | ADRBK1 | 0.97347101 |
| 43 | CSNK1G1 | 0.96913924 |
| 44 | GSK3A | 0.94730704 |
| 45 | EPHA3 | 0.94307864 |
| 46 | PRKCQ | 0.94106567 |
| 47 | PRKD3 | 0.92336606 |
| 48 | PINK1 | 0.88496429 |
| 49 | CSNK1A1L | 0.88112955 |
| 50 | FER | 0.85315852 |
| 51 | CSNK1G3 | 0.84945417 |
| 52 | PNCK | 0.84920821 |
| 53 | MAP3K14 | 0.82878066 |
| 54 | CAMK2G | 0.82494158 |
| 55 | CAMK1G | 0.81277056 |
| 56 | SGK2 | 0.78954839 |
| 57 | NEK9 | 0.78418053 |
| 58 | MAP4K2 | 0.78264835 |
| 59 | BMPR1B | 0.77002993 |
| 60 | PIK3CA | 0.76959700 |
| 61 | IRAK1 | 0.74576739 |
| 62 | PDPK1 | 0.74340491 |
| 63 | CAMK1D | 0.74216278 |
| 64 | SGK3 | 0.73853510 |
| 65 | MAP2K4 | 0.71830847 |
| 66 | IRAK2 | 0.71637226 |
| 67 | PDK2 | 0.71483432 |
| 68 | MAPK11 | 0.71301076 |
| 69 | MAPK12 | 0.71234059 |
| 70 | MAPKAPK5 | 0.70987585 |
| 71 | MAP3K7 | 0.70488872 |
| 72 | ABL2 | 0.68438559 |
| 73 | PRKD1 | 0.67137906 |
| 74 | DAPK2 | 0.66885499 |
| 75 | RIPK1 | 0.66344972 |
| 76 | NEK6 | 0.65627214 |
| 77 | TLK1 | 0.65522717 |
| 78 | CAMK2B | 0.65164848 |
| 79 | CSK | 0.64713097 |
| 80 | MAPK7 | 0.62318957 |
| 81 | LATS1 | 0.62073574 |
| 82 | MYLK | 0.61707499 |
| 83 | MAPK13 | 0.60178317 |
| 84 | KIT | 0.58785718 |
| 85 | MUSK | 0.57589016 |
| 86 | CSNK1G2 | 0.57406645 |
| 87 | NTRK1 | 0.57117350 |
| 88 | LMTK2 | 0.56730198 |
| 89 | AKT3 | 0.55680872 |
| 90 | MAP2K2 | 0.54973596 |
| 91 | NEK2 | 0.54731751 |
| 92 | CAMK2D | 0.54349374 |
| 93 | ICK | 0.54035425 |
| 94 | ITK | 0.53249815 |
| 95 | PAK3 | 0.52793461 |
| 96 | MAPK4 | 0.52288060 |
| 97 | PRKCG | 0.52001810 |
| 98 | TYK2 | 0.51539458 |
| 99 | PRKCE | 0.51253471 |
| 100 | MAP2K6 | 0.49325826 |
| 101 | EPHB2 | 0.48990534 |
| 102 | PRKACG | 0.48721765 |
| 103 | FRK | 0.48545980 |
| 104 | GRK7 | 0.48030636 |
| 105 | JAK2 | 0.47651687 |
| 106 | EPHA4 | 0.46975434 |
| 107 | IGF1R | 0.46687843 |
| 108 | PRKCZ | 0.46387752 |
| 109 | PDK4 | 0.46224914 |
| 110 | PDK3 | 0.46224914 |
| 111 | PRKCA | 0.46063151 |
| 112 | VRK1 | 0.45636047 |
| 113 | JAK1 | 0.44543163 |
| 114 | OBSCN | 0.44194286 |
| 115 | MAP3K3 | 0.44118619 |
| 116 | STK38L | 0.43100625 |
| 117 | MAP2K3 | 0.41317735 |
| 118 | NLK | 0.41144879 |
| 119 | PTK2B | 0.40341968 |
| 120 | CAMK2A | 0.39395461 |
| 121 | PIM1 | 0.38822205 |
| 122 | CSNK1A1 | 0.38320986 |
| 123 | ERBB2 | 0.37995414 |
| 124 | PRKACA | 0.37729723 |
| 125 | NTRK3 | 0.37278591 |
| 126 | PRKAA1 | 0.37113700 |
| 127 | TEC | 0.36822405 |
| 128 | ROCK2 | 0.36550577 |
| 129 | PRKCH | 0.36255248 |
| 130 | TNIK | 0.36114375 |
| 131 | FGR | 0.35765578 |
| 132 | MAP3K12 | 0.35699603 |
| 133 | PRKD2 | 0.35633201 |
| 134 | CASK | 0.34711360 |
| 135 | GRK5 | 0.34304506 |
| 136 | MAP2K1 | 0.34198568 |
| 137 | TAF1 | 0.30572474 |
| 138 | STK11 | 0.30549490 |
| 139 | TYRO3 | 0.29753344 |
| 140 | DDR2 | 0.28959237 |
| 141 | TNK2 | 0.27235468 |
| 142 | PRKCD | 0.26115079 |
| 143 | TXK | 0.24271196 |
| 144 | WEE1 | 0.24070667 |
| 145 | NME1 | 0.22811869 |
| 146 | MATK | 0.22465808 |
| 147 | PRKCI | 0.21733181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.64843419 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.10293396 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.90577336 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.89859440 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.82972299 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.59447976 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.58960321 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.52767698 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.50404832 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45685060 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45008158 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.43131234 |
| 13 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.33477704 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29419841 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.29158907 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.29005495 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.24112376 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.22212413 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.13235908 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 2.12504428 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.11636115 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.01749506 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97667059 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.96248608 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.89285659 |
| 26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.87704156 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87541149 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86330521 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.78302681 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53885990 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.50947449 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.48365278 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46618218 |
| 34 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45739873 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.43293809 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41241182 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.38379305 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.37359087 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.28086135 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.28046486 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21668371 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.20868531 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.19936872 |
| 44 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.18145016 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.17485507 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16275406 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.12891019 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12835570 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12791621 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11584598 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.09194888 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98655085 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98417937 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 0.96741516 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96246852 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94318356 |
| 57 | Phototransduction_Homo sapiens_hsa04744 | 0.92944802 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92593771 |
| 59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.89481200 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87238883 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83783880 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82324086 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.72568589 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70476854 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.70284352 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69069930 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68450772 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56189221 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54517857 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52315355 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51903638 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47987913 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39142050 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38500698 |
| 75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37333256 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.36952537 |
| 77 | Taste transduction_Homo sapiens_hsa04742 | 0.35148854 |
| 78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30325516 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.29357559 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28522445 |
| 81 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.27378052 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.24453542 |
| 83 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.24290128 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23485306 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22490594 |
| 86 | Nicotine addiction_Homo sapiens_hsa05033 | 0.22436788 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.22389674 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21747258 |
| 89 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.21369203 |
| 90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.18557516 |
| 91 | Protein export_Homo sapiens_hsa03060 | 0.14633684 |
| 92 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.13325989 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.12093326 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.10790820 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08786191 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07820154 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.06350445 |
| 98 | Parkinsons disease_Homo sapiens_hsa05012 | 0.06162255 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.06043743 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.05732983 |
| 101 | Cocaine addiction_Homo sapiens_hsa05030 | 0.04807025 |
| 102 | Renin secretion_Homo sapiens_hsa04924 | 0.04317583 |
| 103 | Alzheimers disease_Homo sapiens_hsa05010 | 0.03932987 |
| 104 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.02197837 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.01731158 |
| 106 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.00766415 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.00256424 |
| 108 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.1036183 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0905375 |
| 110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0889006 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0851161 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0836410 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | -0.0705480 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0596367 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0327358 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0137020 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0118107 |
| 118 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0048947 |
| 119 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0015014 |

